NTRR Partner Prepares to Begin Plant Enhancer Case Study at Cannabis Farm in Hawaii
By Business Wire News
By Business Wire News
The U.S. cannabis industry is booming nationwide, creating more and more demand for the unique suite of horticultural products supplied by Neutra Corp. (OTCBB: NTRR) and its joint venture partners. This week, the company is preparing to begin a new case study on its plant enhancer on a medical cannabis farm in the state of Hawaii.
The case study is designed to showcase the plant enhancer’s benefits to crops grown outdoors. The plant enhancer being marketed by NTRR and its joint venture partner, Surface to Air Solutions (S2O2), allows crops to suppress various diseases, retain critical nutrients, reduce water usage, slash pesticide usage, and improve shelf life. The product is biodegradable, non-toxic and non-hazardous, making it ideal for use on cannabis crops and other plants intended for human consumption. One successful case study on the plant enhancer has already been completed in California.
“The plant enhancer has already been shown to be effective on indoor grows, and we’re eager to demonstrate its effectiveness on outdoor crops, too, where pests such as insects can be a larger concern,” said NTRR CEO Chris Brown. “The ultimate aim of our entire suite of horticultural products is to reduce farm production costs by lessening the need for expensive and potentially hazardous pest and disease control measures.”
NTRR and S2O2 have teamed up to market and distribute an all-inclusive horticultural suite that comprises an air scrubber and self-cleaning hard surface treatment in addition to the plant enhancer. Together, these products keep plants and surfaces clean, preventing the buildup of mold, powdery mildew, botrytis, and mites – allowing for healthy plants without the use of pesticides and fungicides.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the development and marketing of natural wellness solutions, including cannabis-related products. By providing a variety of new technologies designed to ensure safer, more reliable access to cannabis in approved markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals (OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp. (OTCBB: EDXC), delivering technological advancements in the cultivation and processing of cannabis in approved markets. For investing information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Chris Brown, 813-367-2041
President and CEO